Business Context and Reporting Period
This Form 8-K was filed by Griffin-American Healthcare REIT IV, Inc. (referenced in metadata as American Healthcare REIT, Inc.) on May 8, 2017. The registrant is an emerging growth company incorporated in Maryland. The report details amendments to a material definitive agreement regarding the acquisition of a senior housing portfolio.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, or liquidity metrics. The only financial figure disclosed is the aggregate contract purchase price for the SW Illinois Senior Housing Portfolio, which is $31,800,000, plus closing costs.
Material Changes and Agreements
The filing reports the execution of amendments to the Purchase and Sale Agreement and the Closing Agreement for the SW Illinois Senior Housing Portfolio, consisting of five facilities in Columbia, Millstadt, Red Bud, and Waterloo, Illinois.
- Second Amendment (May 8, 2017): Extended the Due Diligence Period to 6:00 p.m. Pacific Time on May 10, 2017.
- Third Amendment (May 10, 2017): Replaced the legal description of the Land and required the seller to deliver additional documents at closing as a condition precedent. Notably, failure to meet this condition does not entitle the buyer to recover closing costs upon termination.
- CSL First Amendment (May 10, 2017): Confirmed the form of documents to be used in connection with the closing with CSL-Illinois I, LLC, the future operator.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future performance, or specific risk factors beyond the transactional contingencies noted in the amendments. The transaction remains subject to the conditions outlined in the amended agreements.
Investor Verification Checklist
- Verify the status of the Due Diligence Period following the May 10, 2017 extension.
- Confirm whether the seller has delivered the additional documents required by the Third Amendment.
- Assess the impact of the clause preventing the recovery of closing costs if the deal terminates due to the failure of the new condition precedent.
- Monitor for a subsequent filing confirming the closing of the $31.8 million transaction.